SCHEMBL4601236

SCHEMBL4601236

Cc1cc(-c2cc(C(=O)O)c3ccccc3n2)ccc1Cl

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHODH Q02127 8/20 0.66
KDM4E B2RXH2 3/20 0.65
LMNA P02545 2/20 0.65
SMN1; SMN2 Q16637 2/20 0.65
PDE10A Q9Y233 2/20 0.65
POLB P06746 1/20 0.63
NPC1 O15118 1/20 0.60
ALDH1A1 P00352 1/20 0.60
MAPT P10636 1/20 0.60
HPGD P15428 1/20 0.60
NFKB1 P19838 1/20 0.60
RAB9A P51151 1/20 0.60
NFKB2 Q00653 1/20 0.60
RELA Q04206 1/20 0.60
ATM Q13315 1/20 0.60
NPSR1 Q6W5P4 1/20 0.60
AKR1C3 P42330 1/20 0.60
AKR1C2 P52895 1/20 0.60
AKR1C1 Q04828 1/20 0.60
KMT2A Q03164 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL117357 0.88 DHODH (0.71) DHODHKDM4ELMNASMN1; SMN2PDE10A
SCHEMBL8613147 0.88 DHODH (0.71) DHODHKDM4ELMNASMN1; SMN2PDE10A
SCHEMBL29788462 0.82 DHODH (0.80) DHODHKDM4ELMNASMN1; SMN2PDE10A
SCHEMBL2291034 0.82 DHODH (0.80) DHODHKDM4ELMNASMN1; SMN2PDE10A
SCHEMBL29788466 0.82 DHODH (0.80) DHODHKDM4ELMNASMN1; SMN2PDE10A
SCHEMBL4017739 0.82 DHODH (0.80) DHODHKDM4ELMNASMN1; SMN2PDE10A
SCHEMBL29536364 0.80 DHODH (1.00) DHODHKDM4ELMNASMN1; SMN2PDE10A
SCHEMBL2467110 0.80 DHODH (1.00) DHODHKDM4ELMNASMN1; SMN2PDE10A
Cinchophen SCHEMBL25519 0.80 KDM4E (1.00) DHODHKDM4ELMNASMN1; SMN2PDE10A
Cinchophen SCHEMBL29376617 0.80 KDM4E (1.00) DHODHKDM4ELMNASMN1; SMN2PDE10A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1912970-A2 ACYLTRYPTOPHANOLS FOR FERTILITY CONTROL Bayer Schering Pharma Aktiengesellschaft (DE) 2008-04-23 EP claimed
US-20070060573-A1 Acyltryptophanols BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-03-15 US claimed
WO-2007017289-A2 ACYLTRYPTOPHANOLS FOR FERTILITY CONTROL BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-02-15 WO claimed
EP-1912970-A2 ACYLTRYPTOPHANOLS FOR FERTILITY CONTROL Bayer Schering Pharma Aktiengesellschaft (DE) 2008-04-23 EP disclosed
US-20070060573-A1 Acyltryptophanols BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-03-15 US disclosed
WO-2007017289-A2 ACYLTRYPTOPHANOLS FOR FERTILITY CONTROL BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-02-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070060573-A1 Acyltryptophanols FSHR, NPY1R, NPY2R DHODH 3439/4885KDM4E 2399/4885LMNA 3198/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.